The University of San Francisco

USF Scholarship: a digital repository @ Gleeson Library | Geschke
Center
Master's Projects and Capstones

Theses, Dissertations, Capstones and Projects

Summer 8-16-2022

Social Determinants of Health: Interventions that Improve
Medication Adherence Among People Living With HIV/AIDS
(PLWHA) in Sacramento County
Jehoshaphat Muzungu
kamujungu@gmail.com

Follow this and additional works at: https://repository.usfca.edu/capstone
Part of the Public Health Commons

Recommended Citation
Muzungu, Jehoshaphat, "Social Determinants of Health: Interventions that Improve Medication Adherence
Among People Living With HIV/AIDS (PLWHA) in Sacramento County" (2022). Master's Projects and
Capstones. 1430.
https://repository.usfca.edu/capstone/1430

This Project/Capstone - Global access is brought to you for free and open access by the Theses, Dissertations,
Capstones and Projects at USF Scholarship: a digital repository @ Gleeson Library | Geschke Center. It has been
accepted for inclusion in Master's Projects and Capstones by an authorized administrator of USF Scholarship: a
digital repository @ Gleeson Library | Geschke Center. For more information, please contact repository@usfca.edu.

1

Social Determinants of Health: Interventions that Improve Medication Adherence Among
People Living With HIV/AIDS (PLWHA) in Sacramento County

Jehoshaphat “JM” Muzungu
School of Nursing and Health Professions, University Of San Francisco
Integrated Learning Experience (ILEX) – Summer 2022
MPH 683-28
Dr. Marissa Kraynak
August 15, 2022

2

Contents
Abstract ..................................................................................................................................... 3
Introduction ............................................................................................................................... 5
Background and Literature Review ......................................................................................... 5
HIV Progression...................................................................................................................... 6
Current Interventions.............................................................................................................. 7
Medication Adherence and Viral Suppression .......................................................................... 9
Barriers to Medication Adherence ..........................................................................................11
Medication Fatigue and side effects ......................................................................................11
HIV related stigma...............................................................................................................11
Smoking and substance use ..................................................................................................12
Sexual identity, race, and gender identification ......................................................................12
Other Social Determinants of Health .....................................................................................13
Methods ....................................................................................................................................15
Recommendations......................................................................................................................17
Adopt Multidisciplinary Care Teams at the Implementation Level ...........................................17
Address Social Determinants of Health ...................................................................................20
Housing ..............................................................................................................................20
Food Assistance...................................................................................................................21
Medical Transportation Assistance ........................................................................................21
Implications and Discussion .......................................................................................................23
Limitations ............................................................................................................................24
Future research ......................................................................................................................25
Conclusion.................................................................................................................................26
References .................................................................................................................................27
Appendices ................................................................................................................................33
Appendix 1: Literature Review Table (10 articles) ...................................................................33
Appendix 2: MPH Foundational Competencies .......................................................................37

3

Abstract
Currently, there is still no cure available for the Human Immunodeficiency Virus (HIV). There are
approximately 1.2 million people living with HIV/AIDS, and nearly 36,000 new HIV infections
per year in the U.S alone (HIV.gov, 2021).

Despite the development of highly effective

medications presently used to treat HIV, rates of medication adherence are still low. This paper
explores the interventions that improve medication adherence among people living with
HIV/AIDS (PLWHA) in Sacramento County.
There were approximately 4,403 people living with HIV/AIDS in Sacramento County in
2019, with 158 newly diagnosed in the same year. This high prevalence of HIV/AIDS in
Sacramento County makes the county one of the 48 hotspot counties for HIV/AIDS in the U.S.
(CDPH HIV/AIDS, 2021). In Sacramento County, the highest burden of HIV/AIDS is among
people of color, men who have sex with men, and among the youth (CDPH HIV/AIDS, 2021).
There was a decrease in the rate of viral suppression from 86.76% in 2020 to 85.96% in 2021 in
Sacramento County, a setback in the efforts to reduce the transmission of HIV/AIDS in
Sacramento County.
Based on surveyed literature on medication adherence, this paper recommends the
adoption of multidisciplinary care teams to supplement patient-doctor interactions for individual
people living with HIV/AIDS as a strategy to improve medication adherence and increase rates of
viral suppression in Sacramento County. This paper also recommends addressing specific social
determinants of health such as housing, food, and medication transportation assistance for
PLWHA. Addressing the social determinants of health will incentivize STI testing, increase
retention in care for PLWHA, and help patients achieve viral suppression. Ultimately, this
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approach will most especially improve medication adherence among the economically and racially
marginalized groups.
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Introduction
Background and Literature Review
Globally, about 37.7 million people lived with HIV by the end of the year 2020, with 4%
of this population living in the United States. There were about 1.5 million new HIV infections
worldwide in the year 2020 according to UNAIDS (UNAIDS, 2022). In the United States, about
1.2 million people live with the Human Immunodeficiency Virus, 14% are not aware of their HIV
status. There were approximately 37,000 new infections in the U.S. alone in 2018, with the biggest
burden falling on the southern states of the U.S (HIV.gov, 2021).
According to the California Department of Public Health (CDPH), Sacramento County had
a total of 4,403 People Living with HIV/AIDS (PLWHA) by the year 2019, 158 of whom were
newly diagnosed in the same year (CDPH, 2021). It is important to note Sacramento County had
a population of about 1,578,862 people by the year 2020 (Be Healthy Sacramento, 2022). The high
burden of HIV makes Sacramento County one of the top hotspot counties for HIV/AIDS in the
U.S. (AIDSVU, 2019). Of the 158 newly diagnosed PLWHA, 57% were people of color, while
21.2% were transitional youths ages 13-24. There appears to be a disproportionate impact of HIV
among communities of color and youths in Sacramento County (CDPH, 2021). Black people
accounted for over one fourth (26.7%) of new cases despite only making up about 12% of the
County population. Nonetheless, the highest percentage of new cases (39.8%) of the newly
diagnosed in 2019 were white people (Sacramento Department of Health Services, 2019).
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Figure 1: Burden of HIV in Sacramento County (Sacramento Department of Health Services,
2017)

HIV Progression
The window period for HIV is between two weeks and three months. Most people infected
with HIV will develop acute flu‐like symptoms two to twelve weeks after infection. People
diagnosed with HIV need to be connected and retained in care to manage the HIV infection with
Antiretroviral Therapy (ART). HIV will develop into the acquired immunodeficiency syndrome
(AIDS) if left untreated, which makes victims vulnerable to life‐threatening opportunistic
infections (Prescott Chow, et al., 2020). HIV is most transmitted through six body fluids: blood,
cum, precum, vaginal fluids, rectal fluids, and breast milk. These fluids are most transferred
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between partners through unprotected sexual contact or through sharing equipment for injection
drug use. HIV medications (Antiretroviral Therapy) reduce the risk of HIV transmission and
control the HIV infection by slowing the progression of HIV to AIDS. Pre‐exposure prophylaxis
(PrEP) is part of the current HIV treatment and prevention strategy. PrEP is highly effective in
reducing the risk of HIV transmission among at-risk populations when taken under the direction
of a medical professional.
The current continuum of care for HIV/AIDS highlights the importance of getting tested,
getting linked to care, staying in care, attaining viral suppression, and becoming undetectable
(Rendina, et al., 2020). Achieving the undetectable status (viral load <20 copies/mL) is a very
important part of the strategy to end the HIV epidemic in the United States and beyond. Only
67.9% of people living with HIV/AIDS in The U.S. were virally suppressed in the year 2010
(Cheever, L. 2021). Adherence to HIV medications and care makes PLWHA achieve the
undetectable status, implying they cannot transmit HIV through sex. In other words, Undetectable
= Untransmittable, or U=U (Beyrer, C., et al., 2021).

Current Interventions
In August 1990, the U.S. Congress enacted the Ryan White Comprehensive AIDS
Resources Emergency (CARE) Act, which provides Federal funding for HIV community-based
care and treatment services. The program is managed by the U.S. Health Resources and Services
Administration (HRSA). The CARE Act has been amended and reauthorized four times in 1996,
2000, 2006, and 2009. HRSA awards Ryan White grants to cities, states, counties, and communitybased groups to provide HIV medical care, treatment, and support services for people with HIV;
as well as to improve health outcomes and reduce the transmission of HIV (HRSA, 2020).
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Currently, the Health Resources and Services Administration also runs a federal program
called Ending the HIV Epidemic in the U.S. (EHE), which focuses on reducing the number of new
HIV infections in the United States by at least 90% by the year 2030 (HRSA, 2022).
The Centers for Disease Control (CDC) coordinates HIV surveillance, prevention, and
treatment efforts. The CDC ‘s continuum of HIV care emphasizes getting tested, getting linked to
care, staying in care, achieving viral suppression, and becoming undetectable. The
“Undetectable = Untransmittable” (“U = U”) campaign is backed by the Centers for Disease
Control (CDC), which conveys the message of becoming undetectable to help end the stigma faced
by PLWHA. The stigma around HIV/AIDs is still an obstacle to seeking HIV care. The U=U
campaign creates awareness and protects the wellbeing of people living with HIV by encouraging
them to adhere to medications and maintain the undetectable status and achieving optimum health.
This ultimately addresses the public health goals of preventing HIV and ending the HIV epidemic
in the United States (CDC, 2019).
Sacramento County department of public health supervises the operations of the Ryan
White planning council which assesses the needs of people living with HIV in the transitional grant
area (TGA) and establishes service priorities for PLWHA in the TGA. Transitional Grant Areas
are designations of the Ryan White grant across the United States to ensure effective management
of the grant at the federal level. The Ryan White planning council allocates federal funding to pay
for the delivery of HIV/AIDS medical and support services for those who otherwise could not
afford such services in the Sacramento TGA.
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Medication Adherence and Viral Suppression
HIV medication adherence is an important factor in reducing the HIV viral load among
people living with HIV/AIDS and eliminating the transmission of HIV to uninfected partners
(Tabrisky A.P., et al, 2021). By adhering to daily antiretroviral therapy (ART) medications, people
living with HIV/AIDS can achieve viral suppression (Tchakoute, C.T., et al, 2022). Viral
suppression allows people living with HIV/AIDS to live longer and healthier lives and eliminates
the potential for further transmission to uninfected sexual partners. ART is also emphasized among
people living with HIV/AIDS to reduce individual and community viral load and subsequent risk
of transmission risk (Dangerfield et al., 2018). It is important to note that suboptimal medication
adherence reduces the chances of suppressing the HIV viral load among PLWHA (Tabrisky A.P.,
et al, 2021). Suboptimal medication adherence occurs when a patient misses at least one dose of
medication per month over the course of a three-month period. Suboptimal medication adherence
among youth living with HIV/AIDS has led to poor health outcomes, increased drug resistance,
reduced efficacy of existing treatment options, widened health disparities and the increased
potential for transmission of a drug-resistant virus (Erguera X.A., et al, 2019).
PLWHA are considered virally suppressed when the most recent HIV viral load test result
during the six months after diagnosis is ≤ 200 copies/ml. A person is considered undetectable when
the most recent HIV viral load test result is ≤ 20 copies/ml (CDPH-OA, 2021). In 2021, the number
of virally suppressed people in Sacramento (viral load ≤ 200) reduced from 86.76% in 2020 to
85.96% (Sacramento-tga, 2021). In 2019, the highest viral suppression in California was among
men who have sex with men (71.8%) and the lowest was among men whose mode of transmission
was via injection drug use (41.3%) over a six-month period (CDPH-OA, 2021).
Consistent medication adherence is also associated with both lower viral load levels and
higher CD4 counts which emphasizes the benefits of taking medication adherence for PLWHA
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(Tchakoute, C.T., et al, 2022). There are other benefits of HIV medication adherence. According
to Weinstein et al., having an undetectable viral load for HIV is a driver of higher adherence for
other medical procedures such as mammogram screening among women living with HIV/AIDS.
Weinstein et al. concluded that a decrease in HIV medication adherence is correlated with a decline
in other medical procedures (Weinstein et al., 2016).
Conversely, medication non-adherence has been reported to be the main barrier to
successful HIV treatment and is a risk factor for the emergence of drug resistance (Tchakoute,
C.T., et al, 2022). Among communities of color living with HIV/AIDS, colonial legacies of
medicine, medical mistrust and HIV conspiracy beliefs are contributing factors to medication nonadherence. There is existing uncertainty, misinformation, and mistrust about various aspects of
HIV, particularly among Black and Latinx communities that are borne from the legacies of
institutional racism within medical research and treatment programs (Pasipanodya E.C. et al, 2021;
Liu A.Y., et al, 2016; Mimiaga M.J., et al, 2020). Lower rates of medication adherence have been
reported among black communities due to mistrust of the providers, privacy concerns, lower health
literacy, and unmet medical and social-structural needs (Liu A.Y., et al, 2016; Mimiaga M.J., et
al, 2020). Medical mistrust among the black community is fueled by historical context of unethical
medical experimentation among the black community such as the U.S. Public Health Service
Tuskegee Syphilis Study on Untreated Syphilis among black males in Tuskegee, Alabama
(Brincks et al., 2019). When PLWHA do not trust physicians, health outcomes such as poor
adherence to antiretroviral medications, and intensified psychological distress associated with
treatment for HIV/AIDS have been reported (Brincks et al., 2019). For most communities of color,
the mistrust in medical systems can lead to the reduced belief and understanding of the treatment
benefits, and ultimately poor health care use (Brincks et al., 2019). It is critical to address medical

11

mistrust among the black PLWHA in Sacramento since black people account for over one fourth
of new HIV cases despite only making up about 12% of Sacramento’s population.

Barriers to Medication Adherence
Medication Fatigue and side effects
Several barriers to ART have been widely studied across the globe. Among the youths,
barriers to medication adherence include forgetfulness to take the medications, being away from
home, a change in daily routine, and mental health disorders such as depression, alcohol and
substance abuse (Erguera X.A., et al, 2019). As a key component of the HIV continuum of care,
successful medication adherence has also been affected by medication fatigue and side effects
from the medications (Tabrisky A.P., et al, 2021). Youth are most at risk of poor medication
adherence and hence higher risk of developing high viral loads, predisposing them to living with
AIDS at a young age (Erguera X.A., et al, 2019). Mental health issues such as depression impeded
the ability of young people to prioritize treatment adherence (Dangerfield L.D.T., et al, 2018).
Individuals with depressive symptoms and suboptimal adherence are almost six times more likely
to die than individuals without depressive symptoms who are adherent (Magidson J.F., et al, 2015).

HIV related stigma
HIV related stigma can delay the connection to treatment and care, perpetuate denial of
infection, and influence antiretroviral treatment use and adherence (Yi T., et al, 2011; Dangerfield
L.D.T., et al, 2018). Perceived stigma due to sexual orientation and race is especially a barrier to
medication adherence because it discourages the victims of HIV stigma from seeking care leading
to poor retention in care (Brincks et al., 2019). Discrimination related to HIV diagnoses, physical
and sexual abuse, and diagnoses of mental health disorders and sexually transmitted infections
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among PLWHA has also contributed to HIV related stigma (Johnson et al., 2022). The stigma
associated with HIV destabilizes medication adherence by compromising general psychological
and social support and other adaptive coping mechanisms (Katz et al., 2013). Psychological
processes and stigmatizing attitudes such as internalized stigma and concealment of HIV status
also undermine HIV medication adherence (Katz et al., 2013). HIV stigma may prompt PLWHA
to conceal their seropositivity from others to avoid the unpleasant backlash that may arise from
revealing their status which increases the spread of HIV (Katz et al., 2013).

Smoking and substance use
Smoking and using substances have been reported as a barrier to medication adherence.
Smokers living with HIV/AIDS may have decreased adherence to medications than non-smokers
(Yi T., et al, 2011). Individuals who use substances have been reported to have poorer HIV
medication adherence than those not using substances (Mimiaga M.J., et al, 2020; Dangerfield
L.D.T., et al, 2018). Marquez C., et al, concluded that the association between the use of
methamphetamine and an increased number of sex partners and poor medication adherence
demonstrates the role that substances play in HIV transmission and medication non-adherence
(Marquez C., et al, 2009). Most PLWHA use substances as a coping mechanism to HIV stigma
and mental health related conditions such as anxiety and depression. However, substance
dependence further compromises the ability to consistently adhere to medications (Katz et al.,
2013).

Sexual identity, race, and gender identification
Sexual identity, race, and gender identification are barriers to medications adherence.
Transgender women living with HIV are less likely to report higher adherence to antiretroviral
therapy (ART) compared to other adults living with HIV (Glenda N.B., et al, 2016). ART
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adherence has been associated with older age, abstinence from alcohol, positive gender affirmation
and adherence to hormones among transgender women (Glenda N.B., et al, 2016). Black men who
have sex with men have reported racism, perceived discrimination, and homophobia in healthcare
settings, as barriers to HIV testing and treatment (Dangerfield L.D.T., et al, 2018). HIV-related
stigma, homophobia within the black community, and racism from the white community
contributed to the reluctance to get tested for HIV and increased non-disclosure of a positive HIV
status to sexual partners (Dangerfield L.D.T., et al, 2018). The compounded effect provider
transphobia and stigmatization of transgender people has contributed to the rise in medical mistrust
among the transgender community (Watson C.W., et al, 2020). Transgender people of color,
especially Black and Latino trans people must overcome barriers such as discrimination and
intersectional stigma when seeking for HIV care and gender affirming care (Watson C.W., et al,
2020).

Other Social Determinants of Health
The Weinstein et al. suggests social determinants of health such as lack of employment,
low social support, and drug use, etcetera, have strong implications for HIV medication adherence
and screening (Weinstein et al., 2016). Among racially diverse urban populations of HIV-infected
women engaged in care, social determinants of health are drivers of medication adherence
(Weinstein et al., 2016). Social support from family, friends, medical providers, or other social
determinants of health to motivates medication adherence among people living with HIV
(Pasipanodya E.C. et al, 2021).
Efforts to curb the HIV epidemic in the U.S. must identify factors that influence medication
adherence among racially and ethnically diverse populations. These efforts must also improve Pre
exposure prophylaxis (PrEP) utilization, and design effective interventions among under-
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represented individuals at risk for acquiring HIV (Pasipanodya E.C. et al, 2021). Substance use
and gender-based violence, for example, have been reported to hinder the uptake and adherence to
medication among populations living with HIV/AIDS. Among the transgender community, there
are disproportionately high rates of substance use, and violence which significantly affect
medication adherence (Sevelius J.M., et al, 2021). Exposure to violence is a bigger driver of
medication non-adherence than substance dependence (Sevelius J.M., et al, 2021). Drivers of
medication non-adherence are exacerbated by mental health conditions such as depression.
Individuals with depressive symptoms and suboptimal adherence are almost six times more likely
to die from HIV related illnesses than individuals without depressive symptoms who are adherent
(Magidson J.F., et al, 2015).
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Methods
A review of online literature on medication adherence among people living with
HIV/AIDS in California/Sacramento County published between 2012 and 2022 was conducted
using PubMed and other databases. Data was restricted to studies done in California and most
specifically Sacramento County. A total of 38 articles published between 2012 and 2022 on
PubMed were reviewed. These articles contained data on medication adherence trends and drivers
of medication adherence among people living with HIV/AIDS. The search process included using
search terms as well as the Mesh tool to collect all possible articles on this subject.
Searches included:

“(Sacramento[Title/Abstract]

OR

California[Title/Abstract])

AND

("Medication

Adherence"[Mesh] OR adherence OR compliance OR adherent OR compliant) AND (HIV
OR Antiretroviral OR ART OR HAART OR "Anti-Retroviral Agents"[Mesh] OR "AntiHIV Agents"[Mesh] OR "CCR5 Receptor Antagonists"[Mesh] OR "HIV Fusion
Inhibitors"[Mesh]
Inhibitors"[Mesh]

OR
OR

"HIV
"HIV

Integrase

Inhibitors"[Mesh]

Infections/drug

OR

therapy"[Mesh]

"HIV
OR

Protease
"HIV

Infections"[Mesh])”

AND

“(Social determinants of health[Title/Abstract]) AND (Interventions[Title/Abstract]) AND
("Medication Adherence"[Mesh] OR adherence OR compliance OR adherent OR
compliant) AND (HIV OR Antiretroviral OR ART OR HAART OR "Anti-Retroviral
Agents"[Mesh] OR "Anti-HIV Agents"[Mesh] OR "CCR5 Receptor Antagonists"[Mesh]
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OR "HIV Fusion Inhibitors"[Mesh] OR "HIV Integrase Inhibitors"[Mesh] OR "HIV
Protease Inhibitors"[Mesh] OR "HIV Infections/drug therapy"[Mesh] OR "HIV
Infections"[Mesh])”

AND

“(Interventions[Title/Abstract])

AND

(Sacramento[Title/Abstract]

OR

California[Title/Abstract]) AND ("Medication Adherence"[Mesh] OR adherence OR
compliance OR adherent OR compliant) AND (HIV OR Antiretroviral OR ART OR
HAART OR "Anti-Retroviral Agents"[Mesh] OR "Anti-HIV Agents"[Mesh] OR "CCR5
Receptor Antagonists"[Mesh] OR "HIV Fusion Inhibitors"[Mesh] OR "HIV Integrase
Inhibitors"[Mesh] OR "HIV Protease Inhibitors"[Mesh] OR "HIV Infections/drug
therapy"[Mesh] OR "HIV Infections"[Mesh])”
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Recommendations
Adopt Multidisciplinary Care Teams at the Implementation Level
Multidisciplinary Care Teams (MDCTs) are the mechanism for organizing and coordinating
health and care services to meet the needs of individuals with complex care needs such as PLWHA
(Scie, 2018). MDCTs break disciplinary silos where historically, every profession has tended to
work independently or semi-independently from other disciplines. It is a client-centered approach
where MDCTs assess clients’ unmet needs and collaboratively work together to meet those needs
using a holistic approach to providing care. MDCTs are composed of infectious disease (ID)
doctors, nurses, pharmacists, social workers, medical case managers, non-medical case managers,
mental health clinicians and other health related disciplines. The purpose is for these teams to
collaboratively communicate and work together to achieve optimum care and health of a patient.
In 2012, Horberg M.A., et al. determined there were differences in care optimization among
different MDCTS at several Kaiser Permanente facilities in California. When compared to the HIV
specialist only, MDCTs were found to have statistically significantly greater ART adherence,
suggesting that several MDCT combinations have a positive influence on adherence when
compared to the HIV/ID specialist alone. The Horberg study found the highest mean improved
adherence in the MDCT that include a pharmacist, non-medical case manager and a plus primary
care clinician. Three other MDCT combinations that showed significantly improved adherence
were: nurse, medical case manager and primary care clinician; pharmacist, medical case manager
and a primary care clinician; and infectious disease specialist and mental health clinician. The
study found no statistically significant difference among the different combinations (Horberg
M.A., et al, 2012).
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Figure 2: Roles played by Multidisciplinary Care Teams (CDC, 2022)

Due to their different scopes of practice, nurses, case managers, and social worker teams help
address patient unmet needs and other social determinants of health which increases the likelihood
of medication adherence. It is important to note that HIV care support teams often play a vital role
in supporting PLWHA adhere to HIV medications than the HIV specialist. Prior studies have
indicated that doctors (including infectious disease specialists) do not necessarily emphasize
adherence in their patient interactions (Horberg M.A., et al, 2012). Medical case managers play
crucial roles in improving access to care, increasing rates of retention in care, ensuring treatment
plan adherence, and meeting patient unmet needs. Social workers arrange resources for meeting
social needs such as housing, transportation, insurance benefits and medication availability.
To influence medication adherence, MDCTs are able to create varying degrees of routine and
structure in a patient’s daily life (Magidson J.F., et al, 2015). Higher rates of medication adherence
are associated with changes in lifestyle structure and patterns of activity engagement. For example,
changes in a patient’s daily routine and the patient’s ability to fit a treatment regimen into their
daily routine consistently predicted medication adherence than other factors that affect adherence
(Magidson J.F., et al, 2015).
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Implementation strategy for MDCTs
PLWHA see a variety of health care providers in the health care system. For example, PLWHA
must see infectious disease doctors who monitor disease progress and advise patients and medical
case managers who navigate patients to social services and help them meet their needs. PLWHA
also interact with primary care physicians who prescribe medications, pharmacists who refill
medications, mental health clinicians to help patient deal with mental health issues associated with
living with HIV/AIDS.
The recommendations suggested in this paper focus on creating a web of care where HIV
providers get to know each other the same way PLWHA in Sacramento know their providers.
Often care providers for PLWHA do not know each other which limits collaboration amongst each
other. Using open house events among different local providers as a get together-get to know each
other event, providers of health care for PLWHA in Sacramento will learn about each other’s work,
and devise means to cooperate both professionally and personally for the benefit of the mutually
shared patients. The get together events would be hosted by the different providers who would
take turns hosting the event every year. For most organizations, hosting get-together events is
usually an internally planned event, which means it would add extra costs or require strenuous
planning for the host organization to host other organizations. A major limitation to this idea is
that many providers may not initially buy into this concept. But with time, it is anticipated they
see the benefits of the get together events as mutually beneficial for their clients and come along.
Indicators of success in increasing medication adherence as pertains to this recommendation
will be determined by documented follow up by assigned providers, of particularly identified
patients in specific populations who may have high viral loads. It is anticipated that with care plans
designed for individual patients with high viral loads, these patients adhere to their medications as
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supervised by assigned care providers. With consistent medication adherence, it would take about
six months for these patients to achieve viral suppression and become undetectable.

Address Social Determinants of Health
Housing
Affordable housing has been reported as the greatest barrier to HIV care and medication
adherence (Sacramento-tga, 2021). In 2020, there were an estimated 161,548 people experiencing
homelessness on any given day in California. A total of 9,278 individuals experiencing
homelessness by the start of 2022, according to Sacramento Steps forward (Sacramento Steps
Forward, 2022). In 2022, about 7.1 million Californians were housed but living in poverty, and

56% of that group were spending more than half of their paycheck on rent each month (CDPH,
2022). Housing is particularly stressful for individuals with low or no income, those having
eviction histories, experiencing mental health issues, having criminal records, and those having
current or past drug use (Sacramento-tga, 2021).

Unstable housing is a barrier to viral suppression (Wilson, E. C., et al, 2020). For PLWHA,
housing is a critical need. About 39% of PLWHA in Sacramento reported housing as the biggest
barrier to achieving complete medication adherence in 2021 (Sacramento-tga, 2021). Housing is
necessary to keep PLWHA in HIV medical care and to support their ambulatory medical care
needs. In a 2021 survey, 22% of young adult PLWH in Sacramento reported they were currently
homeless or unstably housed in shelters or motels (Sacramento-tga, 2021). This was slightly higher
than in 2018 where 18.7% of respondents reported homelessness or unstable housing. As the
pandemic and various restrictions exacerbated the scarcity for affordable housing, the need for
mental health services, food vouchers, and housing assistance also increased (Sacramento-tga,
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2021). Since approximately 70.81% of PLWHA in Sacramento live at or below 138% of the
federal poverty level, more resources will be needed to meet the needs of PLWHA in the region
(Sacramento-tga, 2021).

Food Assistance
For many PLWHA not making enough money to buy food and pay bills, not having enough
food can be a barrier to medication adherence. To these people, they must make difficult choices
between buying food to eat to facilitate medication adherence and paying the most urgent bill to
survive getting cut off from basic services. In 2021, Sacramento County reported experiencing a
significant increase in clients seeking housing and food bank services (Sacramento-tga, 2021). As
the pandemic and pandemic-related restrictions continued into 2022, need for mental health
services and food assistance to maintain HIV medical care and medication adherence increased
(Sacramento-tga, 2021).

Medical Transportation Assistance
Field-based medical case management provides transportation assistance to PLWHA and is a
critical component of retaining PLWHA in care. Case managers are able go to the clients’ homes
for visits rather than requiring clients to travel to them, which reduces the transportation costs and
helps overcome the transportation barriers (Sacramento-tga, 2021). In Sacramento County,
inadequate medical transportation assistance has been reported as the second biggest barrier to
HIV care and consequently medication adherence (Sacramento-tga, 2021). Although the bus and
light-rail systems are available in the greater Sacramento area, the outskirts of Sacramento city
have little reach to the public transportation system (Sacramento-tga, 2021). The lack of
transportation to doctor’s visits may cause insufficient doctor’s visits and an inadequate supply of
ART medications or refills, which could perpetuate medication nonadherence among PLWHA.

22

The high costs of transportation to health care appointments may be a barrier to achieving
medication adherence.

Implementation strategy
There is a patchwork of services addressing the social determinants of health among
PLWHA in Sacramento County. While some providers apply for grants and secure funding to
address needs such as housing through federal grants like HOPWA (Housing Opportunity for
people Living With HIV/AIDS), other providers do not. This overwhelms the providers that offer
those services. My recommendation aims at streamlining funding associated with the social
determinants of health so that if providers share the same geographical area of clients, they divide
amongst themselves who provides what service so that a single provider is not overwhelmed with
providing too many services than other providers. If providers do not share the same geographical
area, then those providers should be able to recruit more staff to have the needs of their client
where they are the sole providers of those services. Measures of success will depend on the number
and distribution of grants targeting the specific social determinants of health in the geographical
areas.
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Implications and Discussion
Multiple disciplinary care team members play an integral role in ensuring that HIV
treatment is successful. Coordinated care from multidisciplinary teams improves the rates of
medication adherence and improves other health outcomes too. Given their different professional
backgrounds, multidisciplinary care teams implement holistic approaches to administer care plans
and individual service plans for PLWHA. The different disciplines can examine different
comorbidities of HIV at the same time, and design treatment plans for individual PLWHA.
If they adopted as an HIV care strategy, multidisciplinary care teams will have a significant
impact on medication adherence due to their ability to supplement patient-doctor interactions for
individual PLWHA. While many doctors may not necessarily emphasize adherence in their patient
interactions, multidisciplinary care teams collaboratively supplement patient-doctor interactions.
Inadequate patient-doctor interactions have created an information gap for patients which in turn
contributes to low medication adherence rates.
HIV specialists and mental health clinicians will be able to fully address the significant
impacts of medications for both HIV as well as psychiatric medications on the patient’s ability to
adhere to treatment plans and regimens. For ART, multidisciplinary care teams will be able to
expedite medication access after diagnosis and during continued care visits. Multidisciplinary care
teams will also work together to provide linkage to care after diagnosis for HIV or to an infectious
disease specialist during treatment. The collaborative effort among the different disciplines that
care for PLWHA will improve patient adherence to knowledge about HIV prevention strategies.
Multidisciplinary care teams will educate patients on the role that PLWHA plays toward
reducing the spread of HIV, a vital part of ending the HIV epidemic. They can use financial

24

incentives to support medication adherence which will allow economically vulnerable individuals
to afford other basic needs such as utility bills and transportation to medical appointments.
The high cost of transportation to health care appointments contributes toward medication
non-adherence among poor people. Therefore, providing medical transportation assistance to
financially incentivize HIV/AIDS testing, retention in care, and achieving viral suppression will
improve medication adherence, especially among economically and racially marginalized groups.
Medical transportation assistance will also improve health outcomes among people whose medical
provider is too far from where they live, and they cannot afford transportation because of low pay
because they cannot take time off work or because they cannot afford childcare.
For people with a history of homelessness, financial incentives such as food assistance and
medical transportation assistance are especially important to improve medication adherence and
can be the difference between being a house and facing housing insecurity.

Limitations
Multidisciplinary care teams may not effectively collaborate to improve health outcomes
among PLWHA. Successful multidisciplinary care teams use their specialized knowledge and high
efficiency to perform different tasks to solve patient health problems. A lack of collaboration,
which is often caused by inadequate communication channels and bureaucracy may cause failures
in teamwork which may lead to misunderstanding of individual patient situations. The Successful
collaboration seeks to ask probing questions about the problem, make assessments, and ultimately
make relevant recommendations after group discussions of any given case.
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Addressing the targeted social determinants of health will be limited by unsuccessful grant
applications to fund specific programs in the geographical are, which may skew the distribution of
resources toward certain geographical areas than others. Another limitation is that this literature
review does not put into consideration the impact of Covid-19 on medication adherence in
Sacramento County.

Future research
The impact of substance addiction and homelessness on medication adherence in
Sacramento County. There are gaps in the literature on the compounded impact of substance use
or homelessness on HIV medication adherence. Documenting the compounded impact of either of
these factors in addition to living with HIV/AIDS will highlight the intersection of barriers to
overcoming HIV stigma, addiction, and living with the HIV virus. This will increase awareness of
the impact of homelessness and drug addiction on HIV among PLWHA.
Further research is also required to study the impact of Covid-19 on medication adherence in
Sacramento County.

26

Conclusion
Currently, there is still no cure available for the Human Immunodeficiency Virus (HIV).
There are approximately 1.2 million people living with HIV/AIDS, with approximately 36,000
new HIV infections per year in the U.S alone. Despite the development of highly effective
medications presently used to treat HIV using cutting edge technologies we have today, rates of
medication adherence are still low. This paper has focused on interventions that improve
medication adherence among people living with HIV/AIDS in Sacramento County.
Published studies on medication adherence suggest the adoption of multidisciplinary care
teams to improve medication adherence due to their ability to supplement patient-doctor
interactions for individual people living with HIV/AIDS. Because they are constrained by big
workloads, many doctors don’t necessarily emphasize HIV medications adherence in their patient
interactions. Multidisciplinary care teams collaboratively supplement the doctor-patient
interactions, providing the necessary information and support that HIV patients need to adhere to
medications. Inadequate patient-doctor interactions create an information gap for patients which
translates into low medication adherence rates.
Addressing social determinants of health such as housing, food and medication
transportation assistance has been reported to increase medication adherence among PLWHA.
This paper argues for addressing the social determinants of health to incentivize HIV/AIDS testing,
increase retention in care and help patients achieve viral suppression. This will ultimately improve
medication adherence especially among economically and racially marginalized groups.
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Appendix 2: MPH Foundational Competencies
Competency

APEX Objective or Activity

Evidence-based Approaches to Public Health
1. Apply epidemiological methods to the breadth of
settings and situations in public health practice
2. Select quantitative and qualitative data collection Create
methods appropriate for a given public health context

data

consistency

and

completeness in CRM system.

3. Analyze quantitative and qualitative data using Run monthly reports on Total Case
biostatistics, informatics, computer-based programming Management (Billing) by Case
and software as appropriate

Manager/Client. Food assistance,
Childcare assistance, client lists,
viral and CD4 counts.

4. Interpret results of data analysis for public health Present

reports

research, policy and practice

and

director

5. Compare the organization, structure and function of
health care, public health and regulatory systems across
national and international settings
6. Discuss the means by which structural bias, social
inequities and racism undermine health and create
challenges to achieving health equity at organizational,
community and societal levels

executive

management

decision making.
Public Health & Health Care Systems

to

to
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Planning & Management to Promote Health
7. Assess population needs, assets and capacities that
affect communities' health
8. Apply awareness of cultural values and practices to the
design or implementation of public health policies or
programs
9. Design a population-based policy, program, project or Create
intervention
10. Explain basic principles and tools of budget and
resource management
11. Select methods to evaluate public health programs
Policy in Public Health
12. Discuss multiple dimensions of the policy-making
process, including the roles of ethics and evidence
13. Propose strategies to identify stakeholders and build
coalitions and partnerships for influencing public health
outcomes
14. Advocate for political, social and economic policies
and programs that will improve health in diverse
populations
15. Evaluate policies for their impact on public health and
health equity
Leadership

data

reporting

governance from the CRM.

and
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16. Apply principles of leadership, governance and
management,

which

include

creating

a

vision,

empowering others, fostering collaboration and guiding
decision making
17. Apply negotiation and mediation skills to address
organizational or community challenges
Communication
18. Select communication strategies for different
audiences and sectors
19. Communicate audience-appropriate public health Present

reports

content, both in writing and through oral presentation

and

director

to

executive

management

to

decision making.
20. Describe the importance of cultural competence in
communicating public health content
Interprofessional Practice*
21. Perform effectively on interprofessional teams

Communicate report outcomes to
case managers and mental health
clinicians to improve performance.

Systems Thinking
22. Apply systems thinking tools to a public health issue

